Big Epic Systems database help doctors answer key questions
"This is how real-world evidence can be used," an Epic leader said Tuesday at the Verona company's annual Users Group Meeting.
Stay updated with breaking news from Epic Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"This is how real-world evidence can be used," an Epic leader said Tuesday at the Verona company's annual Users Group Meeting.
Patients were twice as likely to get a colorectal cancer screening and 50% more likely to get a breast cancer screening in their first year of Medicare coverage.
The median life span of people with cystic fibrosis has improved dramatically in recent years, per a new study. Jackie Gerhart, chief medical officer at Epic Research, shared reasons for the improvement.
A new study from Epic Research, a health analytics firm based in Verona, Wisconsin, detected some encouraging news for those who suffer from cystic fibrosis (CF). In 2008, the average life expectancy among CF patients was 26 years -- 65% lower than those without the disease. As of 2022, the life expectancy is 66 years
For breast cancer, 20.5% of patients received a screening in the year prior to being on Medicare, compared to 30.4% in the first year of being on Medicare, according to an Epic Research report. For colorectal cancer, screening rates jumped from 6% in the year before being on Medicare to 11% in the first year of being on Medicare.